TIRRI, Rosella
 Distribuzione geografica
Continente #
EU - Europa 13.571
NA - Nord America 2.824
AS - Asia 2.216
SA - Sud America 352
Continente sconosciuto - Info sul continente non disponibili 209
AF - Africa 33
OC - Oceania 1
Totale 19.206
Nazione #
IT - Italia 7.987
RU - Federazione Russa 3.123
US - Stati Uniti d'America 2.780
SG - Singapore 776
IE - Irlanda 559
CN - Cina 464
UA - Ucraina 393
FR - Francia 323
BR - Brasile 298
GB - Regno Unito 296
NL - Olanda 276
VN - Vietnam 270
HK - Hong Kong 268
DE - Germania 188
KR - Corea 169
FI - Finlandia 122
TR - Turchia 98
SE - Svezia 73
GR - Grecia 67
IN - India 55
JP - Giappone 43
ES - Italia 36
CH - Svizzera 28
PL - Polonia 24
CA - Canada 23
AR - Argentina 20
BE - Belgio 20
BD - Bangladesh 16
AT - Austria 15
EC - Ecuador 13
ID - Indonesia 11
ZA - Sudafrica 10
MX - Messico 9
RO - Romania 9
CO - Colombia 7
UZ - Uzbekistan 7
HR - Croazia 6
IQ - Iraq 6
KE - Kenya 6
PK - Pakistan 6
TW - Taiwan 6
EG - Egitto 5
EU - Europa 5
LT - Lituania 5
MA - Marocco 5
RS - Serbia 5
VE - Venezuela 5
PE - Perù 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
JO - Giordania 3
KZ - Kazakistan 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
NO - Norvegia 2
PH - Filippine 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
KG - Kirghizistan 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
SM - San Marino 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.005
Città #
Moscow 1.141
Dublin 552
Rome 538
Jacksonville 463
Milan 440
Singapore 383
Santa Clara 356
Hong Kong 265
Chandler 253
San Jose 218
Naples 198
Seoul 169
Ashburn 106
Florence 97
Palermo 95
Turin 93
Princeton 85
Ann Arbor 81
Ho Chi Minh City 75
Hanoi 72
Bologna 68
Catania 67
Bari 63
Medford 63
Nanjing 62
Beijing 56
Roxbury 54
Hefei 53
Boardman 50
Dallas 50
Padova 49
San Mateo 43
Verona 43
Helsinki 41
Napoli 41
Woodbridge 41
The Dalles 38
Caserta 37
Wilmington 37
Genoa 34
Cambridge 33
Bengaluru 28
Cagliari 27
Pescara 26
Brescia 25
Taranto 25
Torino 25
Messina 24
Vicenza 24
Venice 23
Da Nang 22
Los Angeles 22
Modena 21
New York 21
Livorno 20
Parma 20
Perugia 20
Des Moines 19
Como 18
Genova 18
Trieste 18
Düsseldorf 16
Reggio Emilia 16
São Paulo 16
Trento 16
Brussels 15
Gorno 15
Reggio Calabria 14
Salerno 14
Bergamo 13
Kunming 13
Nanchang 13
Redwood City 13
Bolzano 12
Belluno 11
Bremen 11
Houston 11
Mountain View 11
Nuremberg 11
Orem 11
Rimini 11
Terni 11
Varese 11
Atlanta 10
Catanzaro 10
Haiphong 10
Hanover 10
Mykolayiv 10
Prato 10
Shanghai 10
Bastia umbra 9
Cosenza 9
Guangzhou 9
Lecce 9
Lucca 9
Marano Di Napoli 9
Sassari 9
Assisi 8
Auburn Hills 8
Carbonera 8
Totale 7.591
Nome #
ARTRITE PSORIASICA ED INTERSTIZIOPATIA POLMONARE : DESCRIZIONE DI UN CASO CLINICO. 8.694
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 303
RAPPORTO TRA QUALITÀ DEL SONNO E DOLORE CRONICO IN PAZIENTI CHE ACCEDONO PER LA PRIMA VOLTA AD UN AMBULATORIO SPECIALISTICO DI REUMATOLOGIA R. Ferrara, D. Capocotta, R. Tirri 266
CROSSLINKS PIRIDINICI URINARI IN PAZIENTI AFFETTI DA SCLEROSI SISTEMICA 192
Antinuclear antibodies in first-degree relatives of patients with polymyositis-dermatomyositis: analysis of the relationship with HLA haplotypes 187
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 186
ESCREZIONE URINARIA DI PIRIDINOLINE IN PAZIENTI DI SCLEROSI SISTEMICA E LUPUS ERITEMATOSO SISTEMICO 175
MANIFESTAZIONI OCULARI NELLA POLI-DERMATOMIOSITE 171
Evidence for bone resorption in systemic sclerosis 167
CROSSLINKS DEL COLLAGENE NELLE URINE DI PAZIENTI SCLERODERMICI: RISULTATI PRELIMINARI 159
INCREASED LEVES OF URINARY PYRIDINIUM CROSSLINKS OF COLLAGEN IN SYSTEMIC SCLEROSIS. 158
[The nephrotic syndrome and pheochromocytoma. A report of a rare clinical case] 154
. ERYTHEMA YRATUM REPENS AND RHEUMATOID ARTHRITIS:CONNECTED FOR THE FIRST TIMe 151
TERAPIA DEL LUPUS ERITEMATOSO SISTEMICO CON MEGADOSI DI METILPREDNISOLONE. RISULTATI ED EFFETTI COLLATERALI IN 14 PAZIENTI. 148
.ANTI-TNF alfa IN PATIENTS WITH EITHER RHEUMATOID ARTHRITIS OR SPONYLOATHRITIS And CONCURRENT C HEPATITIS:A RETROSPECTIVE RECORD REVIEW ON SAFETY 147
Rosacea and abatacept: the first report of a possible correlation 147
30. SULLA EFFICACIA E TOLLERABILITA DELLACQUA MEDIO-MINERALE FONTE LILIA IN PAZIENTI DISPEPTICI ED IPERURICEMICI. 146
ARTHRITIS IS ASSOCIATED WITH PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 146
[Cardiac changes in dermatomyositis] 139
PREVALENCE OF ANTIBODIES RECOGNAIZING CYCLIC CITRULLINATED PEPTIDE(anti CCP) IN PATIENTS WITH ULCERATIVE COLITIS 137
Absence of elevated creatine kinase in dermatomyositis does not exclude malignancy 137
ASSOCIAZIONE CIRROSI BILIARE PRIMITIVA (CBP)/SCLEROSI SISTEMICA SINE SCLERODERMIA (Ssss). 137
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 136
ANTINUCLEAR ANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS: FANA AND ANTIBODIES TO ENA. 135
ANTICORPI ANTICARDIOLIPINA ED ABORTO ABITUALE IN ASSENZA DI ALTRE CAUSE FAVORENTI 131
Cardiac involvement in rheumatoid arthritis: an echocardiographic study 130
[The effect of water with medium mineral content on various biohumoral parameters of uric acid metabolism] 130
ANTI-TOPOISOMERASE I (ANTI-SCL-70) AND CANCER IN SYSTEMIC SCLEROSIS. ARE THEY RELATED? 130
Analisi delle modalità di afferenza e delle caratteristiche cliniche di pazienti con Fenomeno di Raynaud al primo accesso in un ambulatorio specialistico di reumatologia. 127
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases 124
Erythema gyratum repens and rheumatoid arthritis: an unrecognized association? 123
RELAPSING POLYCHONDRITIS. AN HYSTOCHEMICAL STUDY BY LECTIN. 122
METHYPREDNISOLONE PULSE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS (A STUDY OF 11 CASES 122
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 121
[Electromyographic studies in patients with progressive systemic sclerosis] 120
[Clinico-developmental aspects in 44 cases of polymyositis/dermatomyositis] 120
ASPETTI CLINICO-EVOLUTIVI IN 44 CASI DI POLIMIOSITE/ DERMATOMIOSITE 117
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: Results of an Italian observational study 117
Succesfull neridronate therapy in transient osteoporosis of the hip 111
Adult onset Still s Disease:a rare paraneoplastic Syndrome? 111
Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus. 110
Aspetti recenti del termalismo in Campania 110
False positivity of prenatal Down's syndrome and neural-tube tests in SLE 109
CEREBRAL ATROPHY IN SLE PATIENTS: A CONSEQUENCES OF STEROID TREATMENT ? 109
INCIDENZA DI REAZIONI AVVERSE IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE IN TERAPIA CON UN PRIMO E/O UN SECONDO ANTI TNF ALFA 106
IMPIEGO DELLA FANGOBALNEOTERAPIA ALLA LUCE DELLE RECENTI ACQUISIZIONI SULLA CLINICA DELLE MALATTIE REUMATICHE 105
CK MB ED ISOENZIMI 1 E 2 DELLA LAD NELLA PM/DM. 103
MANIFESTAZIONI OCULARI IN GIOVANI ED ADULTI AFFETTI DA MALATTIE REUMATICHE 103
Cerebral atrophy in SLE patients: a consequence of steroid treatment? 103
Incidence of microalbuminuria in obese hypertensive subjects 101
COGANS SYNDROME: A CASE REPORT. 100
Mediterranean Symposium of rheumatology 99
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 99
Leflunomide in psoriatic arthritis: a retrospective study of discontinuation rate in daily clinical practice compared with methotrexate. 98
SUL COMPORTAMENTO DELLA DENSITA MINERALE RADIALE NEGLI OBESI. 98
VALUTAZIONI ECOCARDIOGRAFICHE NEI SOGGETTI OBESI. 98
EFFICACIA TERAPEUTICA DI UNA NUOVA ACQUA OLIGOMINERALE (SORGENTE FONTEVERDE) IN PAZIENTI GOTTOSI. 97
LONG TERM SAFETY OF ANTI -TNF ALFA IN PATIENTS WITH INFLAMMATORY ARTHRITIS AND HBV INFECTION: FOCUS ON HEPATITIS B SURFACE ANTIBODY STATUS 96
The relationship among pain sleep disorders and smoke in patients who assess for the first time in a Rheumatology Unit 96
GOTTA: EVOLUZIONE NON CONTROLLATA NELL’ERA DELL’APPROCCIO “TREAT TO TARGET SERUM URATE” 96
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVES TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES 95
safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice 95
VALUTAZIONI CLINICO-NEUROFISIOLOGICHE IN PAZIENTI CON SCLEROSI SISTEMICA PROGRESSIVA 95
DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SERONEGATIVE SPONDYLOARTHRITIS: ANALYSIS FROM THE MONITORNET DATABASE. 94
Foot involvement in systemic sclerosis: a longitudinal study of 100 patients 93
RS3PE e Diabete Mellito di tipo 2: utilità diagnostica dell’Ultrasonografia 93
EFFECTS OF A REHABILITATION PROGRAM IN FIBROMYALGIA PATIENTS IN PHARMACOLOGICAL TREATMENT 93
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVE TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES. 91
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVE TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES 91
UTILITA DELLA TOMOGRAFIA ASSIALE COMPUTERIZZATA CRANIO-CEREBRALE NEL LUPUS ERITEMATOSO SISTEMICO. 91
QUALITY OF LIFE AND UNMET NEEDS IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES RESULTS FROM THE MULTICENTER, OBSERVATIONAL RAPSODIA STUDY. 90
Sclerosi sistemica 90
Clinical pattern of pain in rheumatoid arthritis 89
EPIDEMIOLOGIA E PREVENZIONE DELLE MALATTIE REUMATICHE 89
IPERSONNOLENZA IN PAZIENTI CON MALATTIE REUMATICHE COMUNEMENTE ASSOCIATE A DOLORE D. Capocotta, R. Ferrara, R. Tirri 89
Evaluation of microalbuminuria in obese subjects with preserved renal function 88
RELEVANCE OF ELECTROPHYSIOLOGICAL INVESTIGATIONS IN SISTEMIC SCLEROSIS 88
SLEEP DISORDERS IN PATIENTS AT THE FIRST ACCESS TO A RHEUMATHOLOGY OUTPATIENT Clinic 87
L’IMPEGNO MUSCOLARE NELLA FASCITE EOSINOFILA: STUDIO ELETTROFISIOLOGICO IN 2 CASI. 86
Pott's disease of the lower cervical spine in a diabetic patient 85
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis 83
DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHROPATHIES. RESULTS FROM THE MONITORNET DATABASE 83
TNF alfa inhibitors and tocilizumab do not influence hepatic steatosis in patients with Rheumatoid arthritis 83
The predictive value of attributes of pain to classify rheumatoid arthritis 81
OCULAR INVOLVEMENT IN POLYMYOSITYS/DERMATOMYOSITIS 79
Un raro caso di artrite post infettiva associata ad ascaridiasi 77
The contribute of sleep quality and mood disturbances on pain perception in patients with rheumatic diseases at first access 74
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 70
Incidental papillary thyroid cancer diagnosis in patientwith adult onset Still disease-like manifestations 69
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 67
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study 62
null 45
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 11
Totale 19.206
Categoria #
all - tutte 44.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.417 0 65 85 85 272 92 92 141 87 151 116 231
2022/20232.283 184 88 85 149 170 168 108 198 626 164 170 173
2023/20241.960 126 94 155 190 292 83 177 213 128 146 188 168
2024/20252.775 122 174 119 183 365 312 285 238 355 251 232 139
2025/20266.107 289 317 304 329 524 3.021 315 319 307 121 150 111
2026/2027233 197 36 0 0 0 0 0 0 0 0 0 0
Totale 19.206